These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 28577689

  • 1. The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs.
    Lunghi C, Moisan J, Grégoire JP, Guénette L.
    Value Health; 2017 Jun; 20(6):728-735. PubMed ID: 28577689
    [Abstract] [Full Text] [Related]

  • 2. The impact of incident depression on medication adherence in patients with type 2 diabetes.
    Lunghi C, Zongo A, Moisan J, Grégoire JP, Guénette L.
    Diabetes Metab; 2017 Dec; 43(6):521-528. PubMed ID: 28822618
    [Abstract] [Full Text] [Related]

  • 3. Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression.
    Lunghi C, Zongo A, Moisan J, Grégoire JP, Guénette L.
    J Diabetes Complications; 2017 Jul; 31(7):1200-1206. PubMed ID: 28325698
    [Abstract] [Full Text] [Related]

  • 4. Incidence of Depression and Associated Factors in Patients With Type 2 Diabetes in Quebec, Canada: A Population-Based Cohort Study.
    Lunghi C, Moisan J, Grégoire JP, Guénette L.
    Medicine (Baltimore); 2016 May; 95(21):e3514. PubMed ID: 27227919
    [Abstract] [Full Text] [Related]

  • 5. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
    Pscherer S, Chou E, Dippel FW, Rathmann W, Kostev K.
    Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545
    [Abstract] [Full Text] [Related]

  • 6. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
    Xing S, Calip GS, Leow AD, Kim S, Schumock GT, Touchette DR, Lee TA.
    J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744
    [Abstract] [Full Text] [Related]

  • 7. The factors associated with insulin nonpersistence in persons with type 2 diabetes.
    Yen FS, Wei JC, Liu JS, Hsu CC, Hwu CM.
    Diabetes Res Clin Pract; 2020 Sep; 167():108356. PubMed ID: 32745695
    [Abstract] [Full Text] [Related]

  • 8. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP, Unger AN, Lustik MB.
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [Abstract] [Full Text] [Related]

  • 9. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.
    Zhang Q, Zhao C, Davies MJ, Radican L, Seck T.
    Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894
    [Abstract] [Full Text] [Related]

  • 10. Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine.
    Rhoads GG, Kosiborod M, Nesto RW, Fonseca VA, Lu SE, Zhang Q, Foody JM.
    Am J Cardiol; 2009 Oct 01; 104(7):910-6. PubMed ID: 19766755
    [Abstract] [Full Text] [Related]

  • 11. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT, Chang KC, Li CY, Wu JS.
    Cardiovasc Diabetol; 2016 Mar 01; 15():41. PubMed ID: 26932742
    [Abstract] [Full Text] [Related]

  • 12. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.
    Clin Ther; 2007 Jun 01; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [Abstract] [Full Text] [Related]

  • 13. Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study.
    Simpson SH, Lin M, Eurich DT.
    Ann Pharmacother; 2016 Sep 01; 50(9):741-6. PubMed ID: 27307411
    [Abstract] [Full Text] [Related]

  • 14. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE, Lee HY, Tong YP, Haines ST.
    Curr Med Res Opin; 2010 Jan 01; 26(1):231-8. PubMed ID: 19921965
    [Abstract] [Full Text] [Related]

  • 15. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH.
    Diabetes Metab Res Rev; 2015 Sep 01; 31(6):619-26. PubMed ID: 25820555
    [Abstract] [Full Text] [Related]

  • 16. Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance.
    Guénette L, Moisan J, Breton MC, Sirois C, Grégoire JP.
    Diabetes Metab; 2013 May 01; 39(3):250-7. PubMed ID: 23523643
    [Abstract] [Full Text] [Related]

  • 17. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
    Cheen HH, Lim SH, Huang MC, Bee YM, Wee HL.
    Clin Ther; 2014 Jul 01; 36(7):1043-53. PubMed ID: 24913030
    [Abstract] [Full Text] [Related]

  • 18. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO, Rascati KL, Lawson KA, Strassels SA.
    Clin Ther; 2012 Mar 01; 34(3):712-9. PubMed ID: 22381712
    [Abstract] [Full Text] [Related]

  • 19. The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes.
    Quilliam BJ, Ozbay AB, Sill BE, Kogut SJ.
    Diabet Med; 2013 Nov 01; 30(11):1305-13. PubMed ID: 23586474
    [Abstract] [Full Text] [Related]

  • 20. Differences in health outcomes associated with initial adherence to oral antidiabetes medications among veterans with uncomplicated Type 2 diabetes: a 5-year survival analysis.
    Gatwood JD, Chisholm-Burns M, Davis R, Thomas F, Potukuchi P, Hung A, Kovesdy CP.
    Diabet Med; 2018 Nov 01; 35(11):1571-1579. PubMed ID: 29978496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.